BioCryst Pharmaceuticals, Inc. $(BCRX)$ is currently at $6.33, down $0.71 or 10.09%
--Would be lowest close since June 28, 2024, when it closed at $6.18
--On pace for largest percent decrease since Nov. 4, 2024, when it fell 12.81%
--Currently down nine of the past 10 days
--Currently down four consecutive days; down 13.05% over this period
--Longest losing streak since Oct. 7, 2025, when it fell for five straight trading days
--Worst four-day stretch since the four days ending Nov. 15, 2024, when it fell 14.16%
--Down 16.6% month-to-date
--Down 15.82% year-to-date; on pace for worst year since 2023, when it fell 47.82%
--Down 80.89% from its all-time closing high of $33.12 on Aug. 25, 2000
--Down 15.37% from 52 weeks ago (Oct. 15, 2024), when it closed at $7.48
--Down 43.43% from its 52-week closing high of $11.19 on June 3, 2025
--Would be a new 52-week closing low
--Traded as low as $6.00; lowest intraday level since June 26, 2024, when it hit $6.00
--Down 14.77% at today's intraday low; largest intraday percent decrease since Nov. 4, 2024, when it fell as much as 18.8%
All data as of 3:21:15 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 14, 2025 15:25 ET (19:25 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.